134 related articles for article (PubMed ID: 25549643)
21. Effect of benazepril on heart rate turbulence in patients with dilated cardiomyopathy.
Zhong JH; Chen XP; Zeng CF; Yun ML; Yang XW; Chen YF; Yao Z
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):612-6. PubMed ID: 17581217
[TBL] [Abstract][Full Text] [Related]
22. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
Liu Y; Ma X; Zheng J; Jia J; Yan T
BMC Nephrol; 2017 Jun; 18(1):206. PubMed ID: 28666408
[TBL] [Abstract][Full Text] [Related]
23. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
[TBL] [Abstract][Full Text] [Related]
24. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
[TBL] [Abstract][Full Text] [Related]
25. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials.
Bangalore S; Fakheri R; Toklu B; Ogedegbe G; Weintraub H; Messerli FH
Mayo Clin Proc; 2016 Jan; 91(1):51-60. PubMed ID: 26763511
[TBL] [Abstract][Full Text] [Related]
27. Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials.
Zhao JD; Jia JJ; Dong PS; Zhao D; Yang XM; Li DL; Zhang HF
BMJ Open; 2018 Aug; 8(8):e020545. PubMed ID: 30166289
[TBL] [Abstract][Full Text] [Related]
28. [Comparative analysis of clinical effects according to syndrome differentiation of Qili Qiangxin Capsules on ischemic heart failure: Meta-analysis].
Sun YL; Ruan XF; Li YP; Wang XL
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4975-4984. PubMed ID: 31872608
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
[TBL] [Abstract][Full Text] [Related]
30. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
31. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
[TBL] [Abstract][Full Text] [Related]
32. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
33. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
[TBL] [Abstract][Full Text] [Related]
35. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].
Zhang GH; Hou FF; Zhang X; Liu QF
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):592-6. PubMed ID: 16194413
[TBL] [Abstract][Full Text] [Related]
36. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
[TBL] [Abstract][Full Text] [Related]
37. Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized controlled trials.
Zhang L; Zhang S; Jiang H; Sun A; Zou Y; Ge J
Clin Cardiol; 2011 Feb; 34(2):117-23. PubMed ID: 21298656
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing recovery of left ventricular structure in patients with chronic heart failure.
Duan HY; Wu XS; Han ZH; Guo YF; Fang SJ; Zhang XX; Wang CM
Chin Med J (Engl); 2011 Sep; 124(18):2868-73. PubMed ID: 22040494
[TBL] [Abstract][Full Text] [Related]
39. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
J Am Coll Cardiol; 2005 Jun; 45(11):1832-9. PubMed ID: 15936615
[TBL] [Abstract][Full Text] [Related]
40. Effect of arotinolol on chronic heart failure: A systematic review and meta-analysis of randomized controlled trials.
Huang P; Song Q; Wang Y; Wang A; Guo L; Zhang H; Zhang Z; Ma X
Front Cardiovasc Med; 2022; 9():1071387. PubMed ID: 36588575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
